Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | 137,60 € | 236,30 € | 71,73 % |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | 130,10 € | 140,60 € | 8,07 % |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | 99,50 € | 184,92 € | 85,85 % |
| Icon plc | 18 | 0 | 3 | 0 | 290,80 € | 319,67 € | 9,93 % |
| United Therapeutics | 18 | 0 | 3 | 0 | 251,80 € | 288,66 € | 14,64 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 19,24 € | 26,01 € | 35,17 % |
| Merit Medical Systems | 17 | 0 | 4 | 0 | 74,00 € | 86,90 € | 17,43 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | 38,40 € | 84,74 € | 120,69 % |
| Insulet Corp. | 16 | 0 | 2 | 0 | 169,60 € | 215,54 € | 27,09 % |
| Amedisys Inc. | 14 | 0 | 1 | 0 | 85,50 € | 92,26 € | 7,91 % |
| Halozyme Therapeutics Inc. | 14 | 0 | 2 | 0 | 41,14 € | 50,33 € | 22,34 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 158,05 € | 184,76 € | 16,90 % |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | 23,02 € | 52,03 € | 126,00 % |
| CONMED Corp. | 12 | 1 | 4 | 0 | 68,00 € | 106,18 € | 56,15 % |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | 76,50 € | 75,94 € | -0,74 % |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | 367,60 € | 421,61 € | 14,69 % |
| QIAGEN NV | 9 | 0 | 0 | 0 | 40,47 € | 47,44 € | 17,22 % |
| Xencor Inc. | 10 | 1 | 1 | 0 | 22,60 € | 32,58 € | 44,15 % |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | 110,00 € | 116,99 € | 6,36 % |
| PTC Therapeutics Inc. | 14 | 5 | 2 | 0 | 31,20 € | 42,12 € | 34,99 % |
| LivaNova plc | 9 | 0 | 3 | 0 | 56,00 € | 66,59 € | 18,92 % |
| MorphoSys AG | 7 | 0 | 0 | 0 | 68,20 € | 65,00 € | -4,69 % |
| Bruker Corp. | 8 | 1 | 1 | 0 | 70,52 € | 84,02 € | 19,15 % |